![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: NDUFA10 |
Gene summary for NDUFA10 |
![]() |
Gene information | Species | Human | Gene symbol | NDUFA10 | Gene ID | 4705 |
Gene name | NADH:ubiquinone oxidoreductase subunit A10 | |
Gene Alias | CI-42KD | |
Cytomap | 2q37.3 | |
Gene Type | protein-coding | GO ID | GO:0006091 | UniProtAcc | A0A024R4B3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
4705 | NDUFA10 | HTA11_3410_2000001011 | Human | Colorectum | AD | 1.88e-02 | -7.85e-02 | 0.0155 |
4705 | NDUFA10 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 2.96e-02 | 5.06e-01 | 0.281 |
4705 | NDUFA10 | A015-C-203 | Human | Colorectum | FAP | 5.49e-17 | -2.72e-02 | -0.1294 |
4705 | NDUFA10 | A002-C-201 | Human | Colorectum | FAP | 1.33e-06 | -1.48e-01 | 0.0324 |
4705 | NDUFA10 | A002-C-203 | Human | Colorectum | FAP | 1.82e-02 | -1.14e-01 | 0.2786 |
4705 | NDUFA10 | A001-C-119 | Human | Colorectum | FAP | 2.32e-03 | -2.99e-01 | -0.1557 |
4705 | NDUFA10 | A001-C-108 | Human | Colorectum | FAP | 8.26e-09 | -1.52e-01 | -0.0272 |
4705 | NDUFA10 | A002-C-205 | Human | Colorectum | FAP | 2.72e-14 | -2.03e-01 | -0.1236 |
4705 | NDUFA10 | A015-C-006 | Human | Colorectum | FAP | 5.46e-08 | -1.28e-01 | -0.0994 |
4705 | NDUFA10 | A015-C-106 | Human | Colorectum | FAP | 1.73e-05 | -1.43e-01 | -0.0511 |
4705 | NDUFA10 | A002-C-114 | Human | Colorectum | FAP | 2.05e-10 | -1.92e-01 | -0.1561 |
4705 | NDUFA10 | A015-C-104 | Human | Colorectum | FAP | 2.11e-18 | -1.74e-01 | -0.1899 |
4705 | NDUFA10 | A001-C-014 | Human | Colorectum | FAP | 4.96e-07 | -9.86e-02 | 0.0135 |
4705 | NDUFA10 | A002-C-016 | Human | Colorectum | FAP | 2.29e-15 | -6.54e-02 | 0.0521 |
4705 | NDUFA10 | A015-C-002 | Human | Colorectum | FAP | 1.45e-06 | -1.53e-01 | -0.0763 |
4705 | NDUFA10 | A001-C-203 | Human | Colorectum | FAP | 1.22e-05 | -2.02e-01 | -0.0481 |
4705 | NDUFA10 | A002-C-116 | Human | Colorectum | FAP | 6.54e-21 | -8.06e-02 | -0.0452 |
4705 | NDUFA10 | A014-C-008 | Human | Colorectum | FAP | 1.49e-06 | -1.59e-01 | -0.191 |
4705 | NDUFA10 | A018-E-020 | Human | Colorectum | FAP | 1.17e-10 | -1.37e-01 | -0.2034 |
4705 | NDUFA10 | F034 | Human | Colorectum | FAP | 1.54e-11 | -7.38e-02 | -0.0665 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000609134 | Thyroid | ATC | generation of precursor metabolites and energy | 256/6293 | 490/18723 | 6.55e-18 | 7.69e-16 | 256 |
GO:004533333 | Thyroid | ATC | cellular respiration | 140/6293 | 230/18723 | 1.76e-17 | 1.89e-15 | 140 |
GO:000611933 | Thyroid | ATC | oxidative phosphorylation | 96/6293 | 141/18723 | 5.40e-17 | 4.88e-15 | 96 |
GO:001598034 | Thyroid | ATC | energy derivation by oxidation of organic compounds | 177/6293 | 318/18723 | 3.60e-16 | 2.92e-14 | 177 |
GO:004277333 | Thyroid | ATC | ATP synthesis coupled electron transport | 69/6293 | 95/18723 | 7.86e-15 | 4.78e-13 | 69 |
GO:004277533 | Thyroid | ATC | mitochondrial ATP synthesis coupled electron transport | 69/6293 | 95/18723 | 7.86e-15 | 4.78e-13 | 69 |
GO:002290034 | Thyroid | ATC | electron transport chain | 106/6293 | 175/18723 | 2.20e-13 | 1.06e-11 | 106 |
GO:002290433 | Thyroid | ATC | respiratory electron transport chain | 76/6293 | 114/18723 | 5.17e-13 | 2.30e-11 | 76 |
GO:001964633 | Thyroid | ATC | aerobic electron transport chain | 62/6293 | 87/18723 | 7.42e-13 | 3.23e-11 | 62 |
GO:003310832 | Thyroid | ATC | mitochondrial respiratory chain complex assembly | 65/6293 | 93/18723 | 8.86e-13 | 3.81e-11 | 65 |
GO:000612032 | Thyroid | ATC | mitochondrial electron transport, NADH to ubiquinone | 40/6293 | 51/18723 | 6.54e-11 | 2.10e-09 | 40 |
GO:001025732 | Thyroid | ATC | NADH dehydrogenase complex assembly | 43/6293 | 57/18723 | 1.20e-10 | 3.75e-09 | 43 |
GO:003298132 | Thyroid | ATC | mitochondrial respiratory chain complex I assembly | 43/6293 | 57/18723 | 1.20e-10 | 3.75e-09 | 43 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa05012 | Colorectum | AD | Parkinson disease | 147/2092 | 266/8465 | 2.53e-27 | 8.48e-25 | 5.41e-25 | 147 |
hsa05208 | Colorectum | AD | Chemical carcinogenesis - reactive oxygen species | 126/2092 | 223/8465 | 1.01e-24 | 1.68e-22 | 1.07e-22 | 126 |
hsa00190 | Colorectum | AD | Oxidative phosphorylation | 86/2092 | 134/8465 | 2.47e-22 | 2.76e-20 | 1.76e-20 | 86 |
hsa05415 | Colorectum | AD | Diabetic cardiomyopathy | 114/2092 | 203/8465 | 3.65e-22 | 3.06e-20 | 1.95e-20 | 114 |
hsa05010 | Colorectum | AD | Alzheimer disease | 174/2092 | 384/8465 | 1.82e-19 | 9.26e-18 | 5.91e-18 | 174 |
hsa05016 | Colorectum | AD | Huntington disease | 147/2092 | 306/8465 | 1.93e-19 | 9.26e-18 | 5.91e-18 | 147 |
hsa04714 | Colorectum | AD | Thermogenesis | 120/2092 | 232/8465 | 2.76e-19 | 1.16e-17 | 7.37e-18 | 120 |
hsa04932 | Colorectum | AD | Non-alcoholic fatty liver disease | 90/2092 | 155/8465 | 4.83e-19 | 1.80e-17 | 1.15e-17 | 90 |
hsa05020 | Colorectum | AD | Prion disease | 133/2092 | 273/8465 | 2.47e-18 | 8.29e-17 | 5.29e-17 | 133 |
hsa05014 | Colorectum | AD | Amyotrophic lateral sclerosis | 164/2092 | 364/8465 | 4.28e-18 | 1.27e-16 | 8.09e-17 | 164 |
hsa05022 | Colorectum | AD | Pathways of neurodegeneration - multiple diseases | 201/2092 | 476/8465 | 4.54e-18 | 1.27e-16 | 8.09e-17 | 201 |
hsa04723 | Colorectum | AD | Retrograde endocannabinoid signaling | 59/2092 | 148/8465 | 2.94e-05 | 2.73e-04 | 1.74e-04 | 59 |
hsa050121 | Colorectum | AD | Parkinson disease | 147/2092 | 266/8465 | 2.53e-27 | 8.48e-25 | 5.41e-25 | 147 |
hsa052081 | Colorectum | AD | Chemical carcinogenesis - reactive oxygen species | 126/2092 | 223/8465 | 1.01e-24 | 1.68e-22 | 1.07e-22 | 126 |
hsa001901 | Colorectum | AD | Oxidative phosphorylation | 86/2092 | 134/8465 | 2.47e-22 | 2.76e-20 | 1.76e-20 | 86 |
hsa054151 | Colorectum | AD | Diabetic cardiomyopathy | 114/2092 | 203/8465 | 3.65e-22 | 3.06e-20 | 1.95e-20 | 114 |
hsa050101 | Colorectum | AD | Alzheimer disease | 174/2092 | 384/8465 | 1.82e-19 | 9.26e-18 | 5.91e-18 | 174 |
hsa050161 | Colorectum | AD | Huntington disease | 147/2092 | 306/8465 | 1.93e-19 | 9.26e-18 | 5.91e-18 | 147 |
hsa047141 | Colorectum | AD | Thermogenesis | 120/2092 | 232/8465 | 2.76e-19 | 1.16e-17 | 7.37e-18 | 120 |
hsa049321 | Colorectum | AD | Non-alcoholic fatty liver disease | 90/2092 | 155/8465 | 4.83e-19 | 1.80e-17 | 1.15e-17 | 90 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
NDUFA10 | SNV | Missense_Mutation | c.206N>A | p.Gly69Glu | p.G69E | O95299 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-D8-A1J8-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | nolvadex | SD | |
NDUFA10 | SNV | Missense_Mutation | novel | c.205N>A | p.Gly69Arg | p.G69R | O95299 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-LD-A66U-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD |
NDUFA10 | insertion | Frame_Shift_Ins | rs746019378 | c.604_605insC | p.His202ProfsTer25 | p.H202Pfs*25 | O95299 | protein_coding | TCGA-AN-A0AJ-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
NDUFA10 | deletion | In_Frame_Del | c.583_585delNNN | p.Ile195del | p.I195del | O95299 | protein_coding | TCGA-D8-A142-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | cyclophosphamid | SD | |||
NDUFA10 | SNV | Missense_Mutation | rs557444462 | c.866N>A | p.Arg289His | p.R289H | O95299 | protein_coding | tolerated(0.57) | possibly_damaging(0.759) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR |
NDUFA10 | SNV | Missense_Mutation | c.287N>T | p.Ser96Ile | p.S96I | O95299 | protein_coding | tolerated(0.15) | benign(0.115) | TCGA-AA-A01R-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | 5-fluorouracil | PD | |
NDUFA10 | SNV | Missense_Mutation | rs558134843 | c.110G>A | p.Arg37His | p.R37H | O95299 | protein_coding | deleterious(0.04) | benign(0.026) | TCGA-AU-6004-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
NDUFA10 | SNV | Missense_Mutation | rs771127541 | c.884N>A | p.Arg295Gln | p.R295Q | O95299 | protein_coding | deleterious(0.02) | benign(0.22) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
NDUFA10 | SNV | Missense_Mutation | c.389N>A | p.Arg130His | p.R130H | O95299 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AZ-6601-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
NDUFA10 | SNV | Missense_Mutation | c.170N>A | p.Ser57Asn | p.S57N | O95299 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-G4-6588-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
4705 | NDUFA10 | ENZYME | inhibitor | CHEMBL3545135 | NV-128 | |
4705 | NDUFA10 | ENZYME | inhibitor | CHEMBL3545320 | ME-344 | |
4705 | NDUFA10 | ENZYME | inhibitor | CHEMBL1703 | METFORMIN HYDROCHLORIDE |
Page: 1 |